VOLITIONRX LTD — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-12-08-05:00

Reporting Person: TERRELL JASON BRADLEY MD (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-08-05:00	Stock Option (Right to Buy)	$3.60	D	55000	Disposed	2026-04-13-05:00	Common Stock (55000)	Direct
2021-12-08-05:00	Stock Option (Right to Buy)	$3.60	A	55000	Acquired	2030-04-13-05:00	Common Stock (55000)	Direct
2021-12-08-05:00	Stock Option (Right to Buy)	$3.60	D	5000	Disposed	2026-04-13-05:00	Common Stock (5000)	Indirect
2021-12-08-05:00	Stock Option (Right to Buy)	$3.60	A	5000	Acquired	2030-04-13-05:00	Common Stock (5000)	Indirect

Footnotes

F1: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant).

F2: The reported transactions involved an amendment of outstanding options granted to the reporting person's wife, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant).